WO2013072935A3 - Process for the preparation of silodosin - Google Patents

Process for the preparation of silodosin Download PDF

Info

Publication number
WO2013072935A3
WO2013072935A3 PCT/IN2012/000670 IN2012000670W WO2013072935A3 WO 2013072935 A3 WO2013072935 A3 WO 2013072935A3 IN 2012000670 W IN2012000670 W IN 2012000670W WO 2013072935 A3 WO2013072935 A3 WO 2013072935A3
Authority
WO
WIPO (PCT)
Prior art keywords
silodosin
preparation
relates
microns
less
Prior art date
Application number
PCT/IN2012/000670
Other languages
French (fr)
Other versions
WO2013072935A2 (en
Inventor
Ashok Prasad
Shriprakash Dhar DWIVEDI
Niraj Kumar Shyamlal SHAH
Jitesh Amratlal DESAI
Original Assignee
Cadila Healthcare Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Limited filed Critical Cadila Healthcare Limited
Publication of WO2013072935A2 publication Critical patent/WO2013072935A2/en
Publication of WO2013072935A3 publication Critical patent/WO2013072935A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a process for preparing silodosin. The invention relates to the preparation of substantially pure silodosin. The invention also relates to silodosin solid particles, wherein 90 volume-percent of the particles (D90) are less than 10 microns and a process for achieving the particle size (D90) less than 10 microns.
PCT/IN2012/000670 2011-10-10 2012-10-10 Process for the preparation of silodosin WO2013072935A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2867MU2011 2011-10-10
IN2867/MUM/2011 2011-10-10

Publications (2)

Publication Number Publication Date
WO2013072935A2 WO2013072935A2 (en) 2013-05-23
WO2013072935A3 true WO2013072935A3 (en) 2013-10-10

Family

ID=47790287

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2012/000670 WO2013072935A2 (en) 2011-10-10 2012-10-10 Process for the preparation of silodosin

Country Status (1)

Country Link
WO (1) WO2013072935A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104230782A (en) * 2013-06-09 2014-12-24 昆明积大制药股份有限公司 Synthetic method of silodosin
ES2607639B1 (en) 2015-09-30 2018-02-28 Urquima, S.A Maleic acid salt of a silodosin intermediate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002265444A (en) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd 1-(3-benzyloxypropyl)-5-(2-substituted propyl) indoline derivative and method for using the same
WO2012062229A1 (en) * 2010-11-12 2012-05-18 Zentiva, K.S. A method of manufacturing (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroethoxy)- phenoxyethyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600675B1 (en) 1992-12-02 1998-07-08 Kissei Pharmaceutical Co., Ltd. Indoline compounds for the treatment of dysuria
UA78854C2 (en) 2002-09-06 2007-04-25 Kissei Pharmaceutical Crystal for an oral solid drug and oral solid drug for dysuria treatment containing the same
BRPI0517515B8 (en) 2004-10-27 2021-05-25 Kissei Pharmaceutical indoline compound, as well as methods for producing indoline compounds
EP2475634B1 (en) 2009-09-12 2017-05-24 Sandoz AG Process for the preparation of indoline derivatives and their intermediates thereof
WO2011101864A1 (en) 2010-02-17 2011-08-25 Panacea Biotec Ltd Novel process for the synthesis of phenoxyethyl derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002265444A (en) * 2001-03-08 2002-09-18 Kissei Pharmaceut Co Ltd 1-(3-benzyloxypropyl)-5-(2-substituted propyl) indoline derivative and method for using the same
WO2012062229A1 (en) * 2010-11-12 2012-05-18 Zentiva, K.S. A method of manufacturing (-)-l-(3-hydroxypropyl)-5-[(2r)-2-({2,2,2-trifluoroethoxy)- phenoxyethyl}amino)propyl]-2,3-dihydro-lh-indole-7-carboxamide

Also Published As

Publication number Publication date
WO2013072935A2 (en) 2013-05-23

Similar Documents

Publication Publication Date Title
HK1208821A1 (en) Core-shell particles, preparation process thereof, and composition containing the same
EP2530049A4 (en) Process for production of spherical aluminum nitride powder, and spherical aluminum nitride powder produced by the process
AU2012234470A8 (en) Self-binding pigment hybrid
EP2774203B8 (en) Method for the preparation of catalyst-coated membranes
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
HUE037271T2 (en) Production of near monodisperse particles using size reduction or growth and membrane separation.
EP2462915A4 (en) Organic-inorganic composite particles and process for production thereof, dispersion containing the particles, and cosmetic containing the particles
WO2012035283A8 (en) Pharmaceutical composition
EP2635257A4 (en) RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs)
EP2714621B8 (en) Method for manufacturing ceramic parts from ceramic particle mixture
EP2669045A4 (en) Fine abrasive particles and process for producing same
WO2011118960A3 (en) Method for preparing nano-particles
WO2010059913A3 (en) Preparation of rasagiline and salts thereof
AU2012301146A8 (en) Process for preparing self-binding pigment particle suspensions
MX2013010889A (en) Process for preparing self-binding pigment particles.
WO2013055684A8 (en) Rasagiline citramide
WO2012121515A3 (en) Copper indium selenide nanoparticles and preparation method thereof
WO2010081480A3 (en) Particles for controlled release of a biocide
WO2010142620A3 (en) Process for the preparation of colloidal systems for the delivery of active compounds
WO2011023783A3 (en) Method for preparing silica particles containing a phthalocyanine derivative, said particles, and uses thereof
EP2442642A4 (en) Stabilized biocidal dispersion via sub-micronized carrier particles, process for making the same and composition thereof
EP2763528B8 (en) Pesticide preparation and process for producing the same
WO2011052940A3 (en) Process for preparing clopidogrel hydrogensulfate form i
WO2013072935A3 (en) Process for the preparation of silodosin
WO2012157872A3 (en) Agglomeration-preventable sweetenersweetener composition in which agglomeration is prevented, and method for preparing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12829166

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12829166

Country of ref document: EP

Kind code of ref document: A2